PHRM 825 Lecture 48- Mens Health Part 1

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/42

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

43 Terms

1
New cards

What happens at puberty

bone and muscle growth

body and facial hair

penis growth

testicular growth

spermatogenesis

increased libido

other changes

2
New cards

mens health issues during puberty

delayed sexual maturity (hypogonadism)

testicular cancer

alopecia

3
New cards

at what age is the onset of puberty

9.5-14 years

4
New cards

what is considered delayed puberty

lack of testicular growth at 14 years old

5
New cards

incomplete/ delayed sexual maturity

usually requires testosterone supplementation

hypogonadism

6
New cards

what is the treatment for hypogonadism

IM testosterone esters

50 mg monthly (max 100 mg)

7
New cards

at what age is testicular cancer most common

15-35

8
New cards

prognosis for testicular cancer

5 year survival rate of 95%

80+% cure rate even if stage III

9
New cards

treatment for testicular cancer

surgery, radiation, chemo

10
New cards

most common alopecia

gradual onset by age 40

heredity plays a factor

androgenic alopecia

11
New cards

autoimmune disorder

hair loss in patches

alopecia areata

12
New cards

complete loss of ALL body hair

alopecia universalis

13
New cards

happens over time from tension on hair from braids, buns, etc

traction alopecia

14
New cards

why does androgenic alopecia occur

excessive conversion of testosterone to DHT

15
New cards

treatment for alopecia and its MOA

Finasteride (Propecia)

inhibits type II 5-alpha reductase (conversion of testosterone to DHT)

16
New cards

dose of finasteride for alopecia

1 mg PO once daily

must be used continuously

17
New cards

another treatment for alopecia and MOA

Minoxidil (Rogaine)

enlarging miniaturized hair follicles, increases blood supply

18
New cards

dose and ROA

topical 5% foam, 5% extra-strength solution

apply to scalp twice daily every day- DRY HAIR and SCALP

19
New cards

combination product for alopecia

topical finasteride/ dutasteride and minoxidil (gel, solution spray)

20
New cards

hormonal deficiency (andropause)

hypogonadism

21
New cards

risk factors for hypogonadism

aging

chronic illness (diabetes, AIDS, rheumatoid arthritis)

long term use of corticosteroids

obesity

22
New cards

diagnosis of hypogonadism

low testosterone levels WITH symptoms

23
New cards

what levels of total testosterone and free testosterone confirm low testosterone

total testosterone level: <300 ng/dl

free testosterone level: <5 ng/dl

24
New cards

specific symptoms of low testosterone

reduced libido

gynecomastia

loss of body hair

reduced muscle bulk and strength

25
New cards

diagnosis of low testosterone

specific signs and symptoms

initial test should be done in the morning and measure total testosterone

total testosterone level <300 ng/dl

free testosterone <5 ng/dl

26
New cards

very high concentrations during part of dosing interval

enanthate or cypionate

100 mg weekly or 200 mg every other week

IM injection

27
New cards

most similar to physiologic testosterone levels

5 mg

patch

28
New cards

5-10 grams applied to covered area of skin daily

1.62%

gel

29
New cards

30-120 mg to arm pits daily

apply deodorant first

solution

30
New cards

30 mg q12h

do not chew or swallow

buccal tablet

31
New cards

implanted q3-6 months

delayed onset (3-4 months)

SQ pellet

32
New cards

Jatenzo

158-237 mg BID

take with food

oral capsule

33
New cards

what is the blackbox warning for gel formulation

concerns w secondary exposure to children

34
New cards

contraindications to testosterone supplementation

prostate cancer

breast cancer

Hct>50%

PSA> 3-4 ng/ml

poorly controlled CVD

35
New cards

when should patients be monitored after initiating therapy and what should their goal testosterone levels be

3-6 months after initiating therapy

goal between 400-700 ng/dl

36
New cards

most common type of cancer in men

prostate cancer

37
New cards

how is treatment of prostate cancer determined

patient age and Gleason score

38
New cards

which location of prostate cancer does not have a 100% 5 year survival rate

distant (bone)= 29%

39
New cards

what are PSA levels in most men without prostate cancer

>4 ng/ml

40
New cards

what PSA level means man has a 25% of having prostate cancer

4-10 ng/ml

41
New cards

what PSA level means the chance of having prostate cancer is over 50%

more than 10

42
New cards

men who have PSA levels of what need retested yearly

greater than or equal to 2.5 ng/ml

43
New cards

which demographics should consider baseline screening at age 40-45

black men and men with FH of prostate cancer